Cystic Fibrosis Trial, Recruiting NCT01852448 Sponsor: Children's Hospital of Philadelphia Condition: Cystic Fibrosis
Back to Cystic Fibrosis

Cystic Fibrosis Trial, Recruiting

NCT01852448
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 2 years of age
  • People who have been diagnosed with Cystic Fibrosis
  • For people under 18 years old, a parent or guardian must give their permission (informed consent), and the child should also agree to take part if they are old enough to do so

Who may not be able to join:

  • People who have been diagnosed with a type of diabetes that is not related to Cystic Fibrosis (for example, Type 1 Diabetes)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrea Kelly, MD, Children's Hospital of Philadelphia

Phone: 267-586-5969

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's Hospital of Philadelphia
Registry
ClinicalTrials.gov
Start date
1 May 2013
Est. completion
1 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Blood sample for DNA to genotype TCF7L2 and about 10 other GWAS-implicated T2DM genes.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov